Rational Design, Chemical Syntheses, and Biological Evaluations of Peripherally Selective Mu Opioid Receptor Ligands as Potential Opioid Induced Constipation Treatment
Boshi Huang,Mengchu Li,Pornprom Klongkumnuankarn,Rolando E. Mendez,James C. Gillespie,David L. Stevens,William L. Dewey,Dana E. Selley,Yan Zhang
DOI: https://doi.org/10.1021/acs.jmedchem.1c02185
IF: 8.039
2022-03-08
Journal of Medicinal Chemistry
Abstract:Opioid-induced constipation (OIC) is a common adverse effect of opioid analgesics. Peripherally acting μ opioid receptor antagonists (PAMORAs) can be applied in the treatment of OIC without compromising the analgesic effects. NAP, a 6β-N-4-pyridyl-substituted naltrexamine derivative, was previously identified as a potent and selective MOR antagonist mainly acting peripherally but with some CNS effects. Herein, we introduced a highly polar aromatic moiety, for example, a pyrazolyl or imidazolyl ring to decrease CNS MPO scores in order to reduce passive BBB permeability. Four compounds 2, 5, 17, and 19, when administered orally, were able to increase intestinal motility during morphine-induced constipation in the carmine red dye assays. Among them, compound 19 (p.o.) improved GI tract motility by 75% while orally administered NAP and methylnaltrexone showed no significant effects at the same dose. Thus, this compound seemed a promising agent to be further developed as an oral treatment for OIC.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c02185.Spectral data for target compounds (1H NMR, 13C NMR, HRMS, and HPLC graphs), in-silico physicochemical properties prediction of target compounds and controls by ACD/Percepta (v2020.2.0) and calculation of CNS MPO scores, raw data of the carmine red dye assay for compound 19, NAP and MNTX using 5 mg/kg morphine, and dose–response antagonism tail-flick studies of compounds 10 and 22 (PDF)Molecular formula strings (CSV)This article has not yet been cited by other publications.
chemistry, medicinal